GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Cyclically Adjusted PS Ratio

argenx SE (argenx SE) Cyclically Adjusted PS Ratio : 65.90 (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Cyclically Adjusted PS Ratio?

As of today (2024-05-27), argenx SE's current share price is $367.07. argenx SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $5.57. argenx SE's Cyclically Adjusted PS Ratio for today is 65.90.

The historical rank and industry rank for argenx SE's Cyclically Adjusted PS Ratio or its related term are showing as below:

ARGX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 65.12   Med: 122.09   Max: 151.79
Current: 65.15

During the past years, argenx SE's highest Cyclically Adjusted PS Ratio was 151.79. The lowest was 65.12. And the median was 122.09.

ARGX's Cyclically Adjusted PS Ratio is ranked worse than
94.67% of 507 companies
in the Biotechnology industry
Industry Median: 5.5 vs ARGX: 65.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

argenx SE's adjusted revenue per share data for the three months ended in Mar. 2024 was $6.761. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


argenx SE Cyclically Adjusted PS Ratio Historical Data

The historical data trend for argenx SE's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Cyclically Adjusted PS Ratio Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 140.03 76.94

argenx SE Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.07 109.85 120.41 76.94 70.63

Competitive Comparison of argenx SE's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, argenx SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where argenx SE's Cyclically Adjusted PS Ratio falls into.



argenx SE Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

argenx SE's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=367.07/5.57
=65.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

argenx SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, argenx SE's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.761/128.5800*128.5800
=6.761

Current CPI (Mar. 2024) = 128.5800.

argenx SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.059 98.360 0.077
201403 0.030 99.390 0.039
201406 0.020 99.240 0.026
201409 0.128 99.960 0.165
201412 0.113 99.050 0.147
201503 0.083 99.750 0.107
201506 0.110 100.230 0.141
201509 0.163 100.500 0.209
201512 0.120 99.730 0.155
201603 0.159 100.310 0.204
201606 0.189 100.260 0.242
201609 0.275 100.570 0.352
201612 0.183 100.710 0.234
201703 0.274 101.440 0.347
201706 0.691 101.370 0.876
201709 0.286 102.030 0.360
201712 0.321 101.970 0.405
201803 0.212 102.470 0.266
201806 0.426 103.100 0.531
201809 0.068 103.950 0.084
201812 0.040 103.970 0.049
201903 1.031 105.370 1.258
201906 0.225 105.840 0.273
201909 0.202 106.700 0.243
201912 0.521 106.800 0.627
202006 0.000 107.510 0.000
202012 0.000 107.850 0.000
202103 3.166 108.870 3.739
202106 5.381 109.670 6.309
202109 0.017 110.790 0.020
202112 0.505 114.010 0.570
202203 0.450 119.460 0.484
202206 1.372 119.050 1.482
202209 2.499 126.890 2.532
202212 3.145 124.940 3.237
202303 3.945 124.720 4.067
202306 4.846 125.830 4.952
202309 5.673 127.160 5.736
202312 6.879 126.450 6.995
202403 6.761 128.580 6.761

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


argenx SE  (NAS:ARGX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


argenx SE Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of argenx SE's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (argenx SE) Business Description

Industry
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.